Norwegian Rituximab Chronic Fatigue Syndrome (ME/CFS) Trial Fails
The outcome of a positive Rituximab trial for ME/CFS – possibly, finally, an FDA approved drug, relief for many, acceptance for this disease, increased research funding – would have been spectacular but Dr. Mella reported this week in Norway that the trial...
“Less Pain, Fewer Pills” – A Fibromyalgia Book Review: Part I
Seeking to curb their misuse, the FDA has come down hard on opioid painkillers, restricting their use, and making it more difficult for some people in chronic pain to gain access to them. Some fibromyalgia patients and their doctors have, not surprisingly, rebelled at...
Easy Does It For Nathalie: A Chronic Fatigue Syndrome (ME/CFS) Improvement Story
A real go-getter, Nathalie hiked, biked and even modeled prior to getting the flu from hell. She tried just about everything she could, and a three year course of Valcyte did help, but when she had to stop the Valcyte she was in real trouble. Reaching outside her...
Treating Autism and ME/CFS: Could One Drug Help Both?
Autism is one of the most treatment resistant conditions there are – which is why the results of Bob Naviaux’s small autism drug trial were so surprising. Despite the fact that only one dose of the drug was given, every autistic child posted a significant...
Glial Cell Inhibitors: The Next Sleep Drugs for Fibromyalgia and Chronic Fatigue Syndrome (ME/CFS)?
Sleep disturbances and severe stress as glial activators: key targets for treating central sensitization in chronic pain patients?Jo Nijs,Marco L. Loggia,Andrea Polli,Maarten Moens,Eva Huysmans,Lisa Goudman, Expert Opinion on Therapeutic Targets Volume 21, 2017...Lives Interrupted Latest Story
Bob Graybosch
Lahaina, United States
Former occupation: Resort General Manager
$1,261,443
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
